In Situ Characterization and Deep Profiling of Engineered Multispecific Nanoparticle Metabolite Coronas for Precise Serum Diagnostics
The paper develops a high-throughput platform that uses engineered magnetic multifunctional nanoparticles to form metabolite biomolecular coronas in serum and then profiles these coronas directly by integrating in situ characterization with MALDI mass spectrometry in a short workflow. Across engineered nanoparticle surface functionalizations, the authors report five distinct metabolite corona composition patterns, including temporal evolution trajectories, and demonstrate that the method can acquire interference-resistant metabolite corona fingerprints on pristine nanoparticle surfaces under protein-coexisting conditions without additional isolation. Using a panel of engineered nanoparticles, the platform profiles 192 clinical serum samples and applies XGBoost with SHAP explainability to decode metabolite corona fingerprints for early detection and biomarker panel screening, reporting AUCs of 0.96–0.99 for endometriosis-associated ovarian cancer. The authors explicitly frame the work as a platform for scalable metabolite corona research and diagnostics, but the summary of study performance is limited to the described assay and dataset rather than broad external validation. This paper is centrally about endometriosis-related diagnosis — it specifically targets endometriosis-associated ovarian cancer using metabolite corona fingerprints for early detection.
Read from the paper's body, not the abstract. Not a substitute for reading the paper. No clinical advice. How this works
Abstract
Full text
4,326 characters
· extracted from
oa-doi-fallback
· click to expand
Text is read by the "Ask this paper" AI Q&A widget below. Extraction quality varies by source — PMC NXML preserves structure cleanly, OA-HTML may include some navigation residue, and OA-PDF can have broken hyphenation. The publisher copy (via DOI) is the canonical version.
My notes (saved in your browser only)
Answers must be backed by verbatim quotes from this paper's full text. Hallucinated quotes are dropped automatically; if no verbatim passage answers the question, we say so. How this works
Condition tags
MeSH descriptors
Funding
- funders
- [{'doi': '10.13039/501100012166', 'name': 'National Key Research and Development Program of China', 'awards': ['2024YFA1307503']}, {'doi': '10.13039/501100012166', 'name': 'National Key Research and Development Program of China', 'awards': ['2024YFC3405402']}, {'doi': '10.13039/501100001809', 'name': 'National Natural Science Foundation of China', 'awards': ['22574028']}]
Citation neighborhood (sparse)
Too few in-corpus citations on either side for a chart; here are the lists.
Cites (4)
References (47)
- Endometriosis via crossref
- Endometriosis-Related Ovarian Cancer: Where Are We Now? A Narrative Review towards a Pragmatic Approach via crossref
- Ovarian cancer. via crossref
- Pathogenesis of Endometriosis and Endometriosis-Associated Cancers via crossref
- doi:10.1038/nnano.2012.207 via crossref
- doi:10.1021/acsnano.4c13214 via crossref
- doi:10.1021/jacs.2c02277 via crossref
- doi:10.1038/s41578-023-00552-2 via crossref
- doi:10.1038/s41580-022-00572-w via crossref
- doi:10.1039/c9en00938h via crossref
- doi:10.1038/s41565-023-01455-7 via crossref
- doi:10.1021/acs.analchem.8b03911 via crossref
- doi:10.1002/smll.202000295 via crossref
- doi:10.1021/acsmeasuresciau.2c00003 via crossref
- doi:10.1038/s41596-024-01009-8 via crossref
- doi:10.1038/s41592-021-01197-1 via crossref
- doi:10.1038/s41467-020-17347-6 via crossref
- doi:10.1073/pnas.2122245119 via crossref
- doi:10.1186/s12951-020-00592-8 via crossref
- doi:10.1039/c5nr08116e via crossref
- doi:10.1039/c8en00161h via crossref
- doi:10.1021/acsnano.3c08391 via crossref
- doi:10.1002/smll.202400941 via crossref
- doi:10.1002/smtd.202401421 via crossref
- doi:10.1002/advs.202302109 via crossref
- doi:10.1002/smtd.202301192 via crossref
- doi:10.1038/s41551-018-0305-z via crossref
- doi:10.3390/metabo10060243 via crossref
- doi:10.1038/s41467-024-46043-y via crossref
- doi:10.1038/s41591-022-01850-y via crossref
- doi:10.1038/nnano.2013.181 via crossref
- doi:10.1002/adma.202206008 via crossref
- doi:10.1021/nn406018q via crossref
- doi:10.1021/ja211307u via crossref
- doi:10.1038/nature04162 via crossref
- doi:10.1038/nmat2442 via crossref
- doi:10.1021/ja2040305 via crossref
- doi:10.1021/acsnano.0c08623 via crossref
- doi:10.1039/c5cs00217f via crossref
- doi:10.1038/196476a0 via crossref
- doi:10.1016/s1470-2045(11)70404-1 via crossref
- doi:10.1002/uog.5365 via crossref
- doi:10.1038/s41571-025-01000-6 via crossref
- doi:10.1016/j.ajog.2016.01.007 via crossref
- doi:10.1038/s41565-021-01017-9 via crossref
- doi:10.1038/s41578-023-00581-x via crossref
- doi:10.1073/pnas.0608582104 via crossref
Source provenance
- crossref
- last seen: 2026-05-17T01:00:10.926782+00:00
- europepmc
- last seen: 2026-06-13T06:22:48.782012+00:00
- pubmed
- last seen: 2026-06-13T06:18:48.313852+00:00
- unpaywall
- last seen: 2026-06-13T06:42:57.164913+00:00
Courtesy of the U.S. National Library of Medicine